CLICHY, France–(BUSINESS WIRE)–CorWave SA, a clinical-stage medical technology company pioneering innovative cardiac assist devices, announces the completion of enrollment in its feasibility study of the CorWave Left Ventricular Assist System (LVAS). The company also presented the first clinical data on the device’s adaptive control algorithm at the 18th Branislav ‘BRANO’ Radovancevic Heart Failure Forum, held jointly with the 19th Innovations and New Treatment Strategies in Heart Failure sym
See full post here as originally published on this site
